The health information technology industry in DACH involves a group of companies that innovate how healthcare is delivered and managed. This sector ranges from startups developing telemedicine platforms to established firms offering electronic health records systems and data analytics tools. As health systems seek efficiencies and improved patient outcomes, there is a growing demand for integrated, tech-driven solutions. The sector is likely heading towards more AI applications and personalized health strategies, paving the way for startups and investors to revolutionize patient care and health management solutions in the region.


In the DACH region, a mix of venture capital firms and corporate investors actively fund health information technology startups. The investors listed range from Calm/Storm in Vienna to Novartis in Basel, showing a geographic spread and industry focus. With a variety of sizes and established years—from 1995 to 2014—they collectively engaged in 219 investment deals in 2024 alone. These investors signify a robust support system, ready to propel innovative health technologies into market relevance.


Top 13 Health Information Technology Investors in DACH


1. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, focusing on purpose-driven founders. Calm/Storm provides capital, support, and networking opportunities to help these companies thrive in the competitive health tech landscape. Their portfolio includes diverse teams addressing sensitive health issues. Notable transactions include Livv Health, which raised over $1.5 million in a pre-seed round in June 2024, and Foundation Health, which secured $6 million in a seed round in March 2024. Additionally, they have been involved with other health tech companies like Healee and kumi health, further solidifying their commitment to the health information technology sector.


2. Verve Ventures

  • Website: verve.vc
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 25
  • LinkedIn: investiere-venture-capital

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus spans various sectors, including climate tech, industrial technology, and notably, health & bio. Verve Ventures has been involved in significant transactions in the health information technology space, such as their investments in DomoHealth, which raised funds through multiple rounds including a Series A and Seed Round, and Piavita, which also secured Series A funding. These investments highlight Verve Ventures' commitment to supporting innovative companies in the health tech sector, making them a relevant player in this industry.


3. Bayern Kapital

  • Website: bayernkapital.de
  • Type: Venture Capital
  • Headquarters: Landshut, Bavaria, Germany
  • Founded year: 1995
  • Headcount: 11-50
  • Number of deals in 2024: 27
  • LinkedIn: bayern-kapital-gmbh

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. They support their clients with financial resources and access to a network of industry experts, helping them navigate the challenges of growth and development in sectors such as life sciences and software. Notably, Bayern Kapital has made significant investments in health information technology, including a Series A investment in ADVANOVA GmbH, which is developing the first mobile electronic patient chart for hospitals. They have also invested in Cliniserve, a company focused on improving hospital workflows, and NeoPrediX, which is involved in health data analytics. These transactions highlight Bayern Kapital's active role in the health IT sector, making them a relevant player in this industry.


4. Novartis

  • Website: novartis.com
  • Type: Corporate
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 10001+
  • Number of deals in 2024: 7
  • LinkedIn: novartis

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company is dedicated to developing and manufacturing innovative medicines that address serious diseases across various therapeutic areas. Novartis emphasizes research and development to enhance patient outcomes globally. In recent years, Novartis has also ventured into health information technology investments, reflecting their commitment to improving healthcare delivery through technology. Notable transactions include a seed investment in Patientory, a health information technology platform that raised $1.5 million in April 2023. Additionally, Novartis has provided grants to health tech startups, such as Medtech Africa, which received funding as part of a broader initiative to support health technology innovations in Africa. Their investment in COTA Healthcare, a company focused on data analytics for cancer care, further highlights their interest in leveraging technology to improve health outcomes.


5. Novartis Venture Fund

  • Website: nvfund.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 10

The Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, the fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping them develop novel therapeutics and address unmet patient needs. Notably, the fund has participated in several significant transactions relevant to health information technology, including a $21.8 million Series C financing round for Ablation Frontiers, which is focused on investigational medical devices, and a $35 million Series D investment in Binx Health, a company that develops health technology solutions for diagnostics. These investments highlight the fund's commitment to advancing healthcare through innovative technologies.


6. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these companies scale their operations. Speedinvest's investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Notably, they have made significant investments in the health information technology sector, including Elephant Healthcare, which raised $13.6 million in Series A funding, and Medicus AI, which secured $682,571 in an Angel Round. Additionally, they led a seed funding round for DasLab, raising €6.2 million, and participated in multiple funding rounds for Doccla, a virtual ward company, including a Series B round of approximately $46 million in 2024. These transactions highlight Speedinvest's active role in supporting health tech innovations.


7. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only capital but also expertise and resources to help these businesses thrive in competitive markets. Among their notable transactions, IBB Ventures invested in Famedly, a startup that raised EUR 2.5 million in seed financing to develop a communication solution aimed at creating a digital data infrastructure for the healthcare sector. This investment highlights their focus on health information technology. Additionally, they have participated in funding rounds for other startups like x-cardiac and Recovery Cat, which may also contribute to advancements in health-related technologies. Overall, IBB Ventures demonstrates a clear interest in supporting innovative solutions within the healthcare industry.


8. Sictic

  • Website: sictic.ch
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2014
  • Headcount: 201-500
  • Number of deals in 2024: 77
  • LinkedIn: sictic

SICTIC is a not-for-profit organization based in Zurich, Switzerland, that connects smart money investors with innovative Swiss early-stage technology startups. Founded in 2014, SICTIC provides investment opportunities, networking events, and educational resources to facilitate the growth of startups and the investment community. Among their notable transactions, SICTIC has invested in health information technology startups such as Komed Health, which raised over $1 million in seed funding to develop a communication platform for healthcare. Additionally, they participated in the seed round for PeriVision, a University of Bern spin-off focused on health technology, which raised between CHF 0.5 and 1 million to accelerate research and development. These investments highlight SICTIC's active role in the health tech sector, making them a relevant player in this field.


9. Debiopharm


Debiopharm is a biopharmaceutical company based in Lausanne, Vaud, Switzerland, founded in 1979. The company specializes in the development and manufacturing of innovative therapies for cancer and infectious diseases, partnering with academic and pharmaceutical institutions to bridge the gap between drug discovery and patient access. In addition to their core focus on biopharmaceuticals, Debiopharm has made significant investments in health information technology. Notable transactions include their participation in Carevive Systems, which raised $18 million in a Series C funding round to enhance its software and analytics platform for clinicians and patients. They also invested in Voluntis, a leader in digital therapeutics, which completed a capital increase to strengthen its financial resources and develop commercial activities with the pharmaceutical industry. Furthermore, Debiopharm co-led a €10 million Series A funding round for Oncomfort, aimed at developing its Digital Sedation solution, and participated in the Series C funding for BC Platforms, a genomic data management company. These investments highlight Debiopharm's engagement in the health information technology sector, showcasing their interest in leveraging technology to improve healthcare outcomes.


10. b2venture

  • Website: b2venture.vc
  • Type: Venture Capital
  • Headquarters: St. Gallen, St. Gallen, Switzerland
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: btovpartners

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, including health information technology. They provide financial backing and support to entrepreneurs, helping them navigate challenges and scale their businesses. Notably, b2venture participated in the Series A funding round for Heartbeat Medical, a German digital health startup, which raised €5M. Additionally, they have invested in Nelly, a fintech startup that is expanding into medical verticals, indicating their interest in the intersection of technology and healthcare. Their collaboration with a community of angel investors enhances their investment strategy, making them a key player in the European venture capital landscape.


11. Wellington Partners


Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, founded in 1998. The firm specializes in life sciences and invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs. Wellington Partners has a strong focus on helping innovative startups develop breakthrough technologies and achieve market success. Notably, they have invested in health information technology through significant transactions such as Sidekick Health, a digital therapeutics company that raised $55 million in a Series B round and $20 million in a Series A round, aimed at expanding its operations in Europe and the US. Additionally, they co-led a €4.5 million Seed Round for nyra health, which is focused on scaling its AI technology in the healthcare sector. These investments highlight Wellington Partners' commitment to advancing health information technology and supporting companies that are transforming healthcare delivery.


12. Leaps by Bayer

  • Website: leaps.bayer.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2015
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: leapsbybayer

Leaps by Bayer is a venture capital investment firm based in Berlin, Germany, founded in 2015. The firm focuses on biotechnology and agriculture, investing in early-stage companies that pursue scientific breakthroughs to tackle significant global challenges in health and food security. In the health information technology sector, Leaps by Bayer has made notable investments, including a Series B funding of approximately $90 million in Ada Health, a company that provides AI-driven health assessments. Additionally, they have invested in Huma, a digital health platform, through multiple funding rounds, including a Series D round of $80 million in 2024 and a Series C round of approximately $130 million in 2021. Their investment in Woebot Health, which focuses on digital therapeutics for mental health, further emphasizes their engagement in the health technology space. By providing funding and active incubation, Leaps by Bayer supports the development of innovative solutions in health technology.


13. HBM Healthcare Investments AG


HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in the healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2022, HBM Healthcare Investments was involved in multiple funding rounds for Farmalisto, a company that has raised significant capital through Series B and convertible note transactions. These investments indicate HBM's active role in supporting innovative healthcare solutions, which may encompass health information technology as part of their broader healthcare investment strategy.



Health Information Technology Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
Calm/StormVienna, Vienna, Austria1-10202013
Verve VenturesZurich, Zurich, Switzerland11-50201025
Bayern KapitalLandshut, Bavaria, Germany11-50199527
NovartisBasel, Basel, Switzerland10001+19967
Novartis Venture FundBasel, Basel, Switzerland11-50199610
SpeedinvestVienna, Vienna, Austria51-200201145
IBB VenturesBerlin, Berlin, Germany11-50199718
SicticZurich, Zurich, Switzerland201-500201477
DebiopharmLausanne, Vaud, Switzerland201-50019794
b2ventureSt. Gallen, St. Gallen, Switzerland11-50200015
Wellington PartnersMunich, Bavaria, Germany11-5019989
Leaps by BayerBerlin, Berlin, Germany11-50201516
HBM Healthcare Investments AGZug, Zug, Switzerland1001-500020018


Want to find more investors focusing on the health information technology industry?

If you want to find more investors that are active in the health information technologyindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!